In both the OPTIMISTIC and DMBDI studies, the data suggest pathway related changes in OX40 and SLE signaling, indicating an impairment in immunity with increasing DM1 severity [47]. This evidence concerns the gene TNFRSF4 and myotonic dystrophy type 1.